{"id":8828,"date":"2025-08-24T10:56:53","date_gmt":"2025-08-24T08:56:53","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/"},"modified":"2025-08-24T10:56:55","modified_gmt":"2025-08-24T08:56:55","slug":"la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/","title":{"rendered":"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2025\/fda-approves-sublingua.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2025\/fda-approves-sublingua.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 des comprim\u00e9s sublinguaux de Tonmya (chlorhydrate de cyclobenzaprine) pour le traitement de la fibromyalgie chez les adultes.<\/p>\n<p>L&rsquo;approbation est la premi\u00e8re pour un traitement de la fibromyalgie en plus de 15 ans. Il s&rsquo;agit d&rsquo;un analg\u00e9sique au coucher une fois en classe, non opio\u00efde, une fois par jour.<\/p>\n<p>L&rsquo;approbation \u00e9tait bas\u00e9e sur deux essais cliniques de phase 3 de pr\u00e8s de 1 000 patients, ce qui a montr\u00e9 que Tonmya r\u00e9duisait consid\u00e9rablement les scores de la douleur quotidienne par rapport au placebo \u00e0 14 semaines. Par rapport \u00e0 ceux qui re\u00e7oivent un placebo, un pourcentage plus \u00e9lev\u00e9 de participants prenant Tonmya a connu une am\u00e9lioration cliniquement significative (\u2265 30%) de leur douleur apr\u00e8s trois mois.<\/p>\n<p>Dans les essais \u00e0 trois phases 3 impliquant plus de 1 400 patients, Tonmya \u00e9tait g\u00e9n\u00e9ralement bien tol\u00e9r\u00e9e, les \u00e9v\u00e9nements ind\u00e9sirables les plus courants (incidence, \u2265 2%) \u00e9tant un engourdissement dans la bouche, l&rsquo;inconfort oral, le go\u00fbt anormal du produit, la drote et les picotements ou les br\u00fblures dans la bouche, la douleur orale, la fatigue, la bouche s\u00e8che et les canons an\u00e9mphthmes.<\/p>\n<p>\u00ab\u00a0Chez Tonix, nous avons reconnu le potentiel transformateur de poursuivre une nouvelle approche avec Tonmya pour la fibromyalgie, une condition de douleur chronique qui se chevauchent qui s&rsquo;est d\u00e9roul\u00e9e sans innovation depuis de nombreuses ann\u00e9es\u00a0\u00bb, a d\u00e9clar\u00e9 Seth Lederman, MD, PDG de Tonix Pharmaceuticals, dans un communiqu\u00e9. \u00ab\u00a0Nous esp\u00e9rons que le traitement efficace de la douleur avec Tonmya pourrait aider \u00e0 am\u00e9liorer la vie des personnes atteintes de ce syndrome chronique.\u00a0\u00bb<\/p>\n<p>L&rsquo;approbation de Tonmya a \u00e9t\u00e9 accord\u00e9e \u00e0 Tonix Pharmaceuticals.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 des comprim\u00e9s sublinguaux de Tonmya (chlorhydrate<\/p>\n","protected":false},"author":1,"featured_media":8829,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[321,447,6401,4339,2564,6400,261],"class_list":["post-8828","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-approuve","tag-fda","tag-fibromyalgie","tag-opioide","tag-quotidien","tag-sublingual","tag-traitement","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 des comprim\u00e9s sublinguaux de Tonmya (chlorhydrate\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T08:56:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-24T08:56:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie\",\"datePublished\":\"2025-08-24T08:56:53+00:00\",\"dateModified\":\"2025-08-24T08:56:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/\"},\"wordCount\":299,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg\",\"keywords\":[\"approuve\",\"FDA\",\"fibromyalgie\",\"opio\u00efde\",\"quotidien\",\"sublingual\",\"traitement\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/\",\"name\":\"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg\",\"datePublished\":\"2025-08-24T08:56:53+00:00\",\"dateModified\":\"2025-08-24T08:56:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg\",\"width\":1280,\"height\":853,\"caption\":\"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/","og_locale":"fr_FR","og_type":"article","og_title":"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie - RVH-Synergie.org","og_description":"La Food and Drug Administration des \u00c9tats-Unis a approuv\u00e9 des comprim\u00e9s sublinguaux de Tonmya (chlorhydrate","og_url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/","og_site_name":"RVH-Synergie","article_published_time":"2025-08-24T08:56:53+00:00","article_modified_time":"2025-08-24T08:56:55+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie","datePublished":"2025-08-24T08:56:53+00:00","dateModified":"2025-08-24T08:56:55+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/"},"wordCount":299,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg","keywords":["approuve","FDA","fibromyalgie","opio\u00efde","quotidien","sublingual","traitement"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/","url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/","name":"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg","datePublished":"2025-08-24T08:56:53+00:00","dateModified":"2025-08-24T08:56:55+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/08\/1756025813_La-FDA-approuve-le-traitement-quotidien-sublingual-et-non-opioide.jpg","width":1280,"height":853,"caption":"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-le-traitement-quotidien-sublingual-et-non-opioide-de-la-fibromyalgie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"La FDA approuve le traitement quotidien sublingual et non opio\u00efde de la fibromyalgie"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/8828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=8828"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/8828\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/8829"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=8828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=8828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=8828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}